Semin Respir Crit Care Med 2005; 26(2): 253-262
DOI: 10.1055/s-2005-869544
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Emerging Concepts in Outcome Assessment for COPD Clinical Trials

Sanjay A. Patel1 , Frank C. Sciurba1
  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
Further Information

Publication History

Publication Date:
27 April 2005 (online)

ABSTRACT

The selection of appropriate, clinically meaningful outcome measures for chronic obstructive pulmonary disease (COPD) clinical trials is a complex issue. Functional exercise measures are more likely to adequately reflect the effect of novel and emerging interventions than traditional physiological measures such as forced expiratory volume in 1 second (FEV1). Nonetheless, among several exercise measures commonly used, the choice is not a simple issue and should be based upon rational as well as pragmatic issues. This is because important measurement properties (validity and responsiveness) can differ among exercise measures, among different interventions, and across degrees of disability. Furthermore, “free-living” daily activity measures may be more meaningful measures than these “in-lab” exercise measures for future clinical trials of COPD, although their reproducibility, validity, and responsiveness have not yet been adequately studied. Application of these and other emerging concepts in outcome assessment for COPD clinical trials will be examined.

REFERENCES

  • 1 Mannino D, Homma D, Akinbami L et al.. Chronic Obstructive Pulmonary Disease Surveillance: United States, 1971-2000. Hyattsville, MD; National Center for Health Statistics 2000
  • 2 Michaud C M, Murray C J, Bloom B R. Burden of disease: implications for future research.  JAMA. 2001;  285 535-539
  • 3 Lopez A, Murray C. The global burden of disease 1990-2000.  Nat Med. 1998;  4 1241-1243
  • 4 Sullivan S D, Ramsey S D, Lee T A. The economic burden of COPD.  Chest. 2000;  117 5S-9S
  • 5 Barnes P J. New treatments for COPD.  Nat Rev Drug Discov. 2002;  1 437-446
  • 6 Casaburi R, Mahler D A, Jones P W et al.. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.  Eur Respir J. 2002;  19 217-224
  • 7 Kilfeather S. 5-lipoxygenase inhibitors for the treatment of COPD.  Chest. 2002;  121 197S-200S
  • 8 De Boer W I. Cytokines and therapy in COPD: a promising combination?.  Chest. 2002;  121 209S-218S
  • 9 MacNee W. Oxidants/antioxidants and COPD.  Chest. 2000;  117 303S-317S
  • 10 Compton C H, Gubb J, Nieman R et al.. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.  Lancet. 2001;  358 265-270
  • 11 Fujie K, Shinguh Y, Inamura N et al.. Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043.  Eur J Pharmacol. 1999;  374 117-125
  • 12 Mao J T, Goldin J G, Dermand J et al.. A pilot study of all-trans-retinoic acid for the treatment of human emphysema.  Am J Respir Crit Care Med. 2002;  165 718-723
  • 13 Croxton T L, Weinmann G G, Senior R M, Hoidal J R. Future research directions in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2002;  165 838-844
  • 14 Fishman A P. Pulmonary rehabilitation research.  Am J Respir Crit Care Med. 1994;  149 825-833
  • 15 Guyatt G H, Thompson P J, Berman L B et al.. How should we measure function in patients with chronic heart and lung disease?.  J Chronic Dis. 1985;  38 517-524
  • 16 Fink G, Moshe S, Goshen J et al.. Functional evaluation in patients with chronic obstructive pulmonary disease: pulmonary function test versus cardiopulmonary exercise test.  J Occup Environ Med. 2002;  44 54-58
  • 17 Franciosa J A, Park M, Levine T B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.  Am J Cardiol. 1981;  47 33-39
  • 18 Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease.  Chest. 1989;  96 1247-1251
  • 19 Gorkin L, Norvell N K, Rosen R C et al.. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy.  Am J Cardiol. 1993;  71 1069-1073
  • 20 Mahler D A, Harver A. Prediction of peak oxygen consumption in obstructive airway disease.  Med Sci Sports Exerc. 1988;  20 574-578
  • 21 Matthews J I, Bush B A, Ewald F W. Exercise responses during incremental and high intensity and low intensity steady state exercise in patients with obstructive lung disease and normal control subjects.  Chest. 1989;  96 11-17
  • 22 Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.  Am Rev Respir Dis. 1992;  145 1321-1327
  • 23 Fishman A, Martinez F, Naunheim K et al.. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.  N Engl J Med. 2003;  348 2059-2073
  • 24 Ries A L, Kaplan R M, Limberg T M, Prewitt L M. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease.  Ann Intern Med. 1995;  122 823-832
  • 25 O'Donnell D E, Webb K A. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation.  Am Rev Respir Dis. 1993;  148 1351-1357
  • 26 Wasserman K, Hansen J, Sue D et al.. Principles of Exercise Testing and Interpretation. Philadelphia; Lippincott Williams & Wilkins 1999
  • 27 Morgan A D, Peck D F, Buchanan D R, McHardy G J. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis.  Br Med J (Clin Res Ed). 1983;  286 171-173
  • 28 Statement A TS. Guidelines for the six-minute walk test.  Am J Respir Crit Care Med. 2002;  166 111-117
  • 29 Casaburi R. Skeletal muscle function in COPD.  Chest. 2000;  117 267S-271S
  • 30 Donahoe M. Nutritional aspects of lung disease.  Respir Care Clin N Am. 1998;  4 85-112
  • 31 Schols A M, Soeters P B, Dingemans A M et al.. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation.  Am Rev Respir Dis. 1993;  147 1151-1156
  • 32 Schols A M, Mostert R, Soeters P B et al.. Nutritional state and exercise performance in patients with chronic obstructive lung disease.  Thorax. 1989;  44 937-941
  • 33 Mostert R, Goris A, Weling-Scheepers C et al.. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.  Respir Med. 2000;  94 859-867
  • 34 Yoshikawa M, Yoneda T, Takenaka H et al.. Distribution of muscle mass and maximal exercise performance in patients with COPD.  Chest. 2001;  119 93-98
  • 35 Baarends E M, Schols A M, Mostert R, Wouters E F. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease.  Eur Respir J. 1997;  10 2807-2813
  • 36 Palange P, Forte S, Felli A et al.. Nutritional state and exercise tolerance in patients with COPD.  Chest. 1995;  107 1206-1212
  • 37 Palange P, Forte S, Onorati P et al.. Effect of reduced body weight on muscle aerobic capacity in patients with COPD.  Chest. 1998;  114 12-18
  • 38 Haccoun C, Smountas A A, Gibbons W J et al.. Isokinetic muscle function in COPD.  Chest. 2002;  121 1079-1084
  • 39 Killian K J, Summers E, Jones N L, Campbell E J. Dyspnea and leg effort during incremental cycle ergometry.  Am Rev Respir Dis. 1992;  145 1339-1345
  • 40 Man W D, Soliman M G, Gearing J et al.. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2003;  168 562-567
  • 41 Gosker H R, Lencer N H, Franssen F M et al.. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD.  Chest. 2003;  123 1416-1424
  • 42 Saey D, Debigare R, LeBlanc P et al.. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2003;  168 425-430
  • 43 Jeffery Mador M, Kufel T J, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2000;  161 447-453
  • 44 Casaburi R, Patessio A, Ioli F et al.. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease.  Am Rev Respir Dis. 1991;  143 9-18
  • 45 Maltais F, Simard A A, Simard C et al.. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.  Am J Respir Crit Care Med. 1996;  153 288-293
  • 46 Agusti A G, Sauleda J, Miralles C et al.. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2002;  166 485-489
  • 47 Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure.  Eur Respir J. 1990;  3 192-196
  • 48 Gosker H R, van Mameren H, van Dijk P J et al.. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease.  Eur Respir J. 2002;  19 617-625
  • 49 Eid A A, Ionescu A A, Nixon L S et al.. Inflammatory response and body composition in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1414-1418
  • 50 Takabatake N, Nakamura H, Abe S et al.. Circulating leptin in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  159 1215-1219
  • 51 Wouters E F, Creutzberg E C, Schols A M. Systemic effects in COPD.  Chest. 2002;  121 127S-130S
  • 52 Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain.  Chest. 2001;  119 256-270
  • 53 McGavin C R, Gupta S P, McHardy G J. Twelve-minute walking test for assessing disability in chronic bronchitis.  BMJ. 1976;  1 822-823
  • 54 Butland R J, Pang J, Gross E R et al.. Two-, six-, and 12-minute walking tests in respiratory disease.  Br Med J (Clin Res Ed). 1982;  284 1607-1608
  • 55 Cooper K H. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing.  JAMA. 1968;  203 201-204
  • 56 Troosters T, Vilaro J, Rabinovich R et al.. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease.  Eur Respir J. 2002;  20 564-569
  • 57 Alison J A, Anderson S D. Comparison of two methods of assessing physical performance in patients with chronic airway obstruction.  Phys Ther. 1981;  61 1278-1280
  • 58 Swinburn C R, Wakefield J M, Jones P W. Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease.  Thorax. 1985;  40 581-586
  • 59 Faggiano P, D'Aloia A, Gualeni A, Giordano A. Assessment of oxygen uptake during the six-minute walk test in patients with heart failure.  Chest. 1997;  111 1146
  • 60 Riley M, McParland J, Stanford C F, Nicholls D P. Oxygen consumption during corridor walk testing in chronic cardiac failure.  Eur Heart J. 1992;  13 789-793
  • 60a Onorati P, Antonucci R, Valli G et al.. Noninvasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients.  Eur J Appl Physiol. 2003;  89 331-336
  • 61 Singh S J, Morgan M D, Scott S et al.. Development of a shuttle walking test of disability in patients with chronic airways obstruction.  Thorax. 1992;  47 1019-1024
  • 62 Singh S J, Morgan M D, Hardman A E et al.. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.  Eur Respir J. 1994;  7 2016-2020
  • 63 Revill S M, Morgan M D, Singh S J et al.. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease.  Thorax. 1999;  54 213-222
  • 64 Guyatt G H, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties?.  J Clin Epidemiol. 1992;  45 1341-1345
  • 65 Kessler R, Faller M, Fourgaut G et al.. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  159 158-164
  • 66 Oga T, Nishimura K, Tsukino M et al.. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease.  Heart Lung. 2002;  31 374-381
  • 67 Elpern E H, Stevens D, Kesten S. Variability in performance of timed walk tests in pulmonary rehabilitation programs.  Chest. 2000;  118 98-105
  • 68 Brown S E, Wiener S, Brown R A et al.. Exercise performance following a carbohydrate load in chronic airflow obstruction.  J Appl Physiol. 1985;  58 1340-1346
  • 69 Sciurba F, Criner G J, Lee S M et al.. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length.  Am J Respir Crit Care Med. 2003;  167 1522-1527
  • 70 Guyatt G H, Pugsley S O, Sullivan M J et al.. Effect of encouragement on walking test performance.  Thorax. 1984;  39 818-822
  • 71 Noseda A, Carpiaux J P, Prigogine T, Schmerber J. Lung function, maximum and submaximum exercise testing in COPD patients: reproducibility over a long interval.  Lung. 1989;  167 247-257
  • 72 Morales F J, Montemayor T, Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure.  Int J Cardiol. 2000;  76 101-105
  • 73 Stevens D, Elpern E, Sharma K et al.. Comparison of hallway and treadmill six-minute walk tests.  Am J Respir Crit Care Med. 1999;  160 1540-1543
  • 74 Swerts P M, Mostert R, Wouters E F. Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease.  Phys Ther. 1990;  70 439-442
  • 75 Revill S M, Beck K E, Morgan M D. Comparison of the peak exercise response measured by the ramp and 1-min step cycle exercise protocols in patients with exertional dyspnea.  Chest. 2002;  121 1099-1105
  • 76 Parameswaran S I, Slivka W A, Bauldoff G S, Sciurba F C. Variations in cardiopulmonary exercise testing protocol affects measured outcome parameters of aerobic performance in severe COPD [abstract].  Chest. 1999;  116(suppl 2) 332S
  • 77 Myers J, Buchanan N, Walsh D et al.. Comparison of the ramp versus standard exercise protocols.  J Am Coll Cardiol. 1991;  17 1334-1342
  • 78 Debigare R, Maltais F, Mallet M et al.. Influence of work rate incremental rate on the exercise responses in patients with COPD.  Med Sci Sports Exerc. 2000;  32 1365-1368
  • 79 Lacasse Y, Wong E, Guyatt G H et al.. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.  Lancet. 1996;  348 1115-1119
  • 80 Leggett R J, Flenley D C. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale.  BMJ. 1977;  2 84-86
  • 81 Criner G J, Cordova F C, Furukawa S et al.. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  160 2018-2027
  • 82 Pompeo E, Marino M, Nofroni I et al.. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group.  Ann Thorac Surg. 2000;  70 948-953 , discussion 954
  • 83 Liesker J J, Wijkstra P J, Ten Hacken N H et al.. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD.  Chest. 2002;  121 597-608
  • 84 Oga T, Nishimura K, Tsukino M et al.. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease: a comparison of three different exercise tests.  Am J Respir Crit Care Med. 2000;  161 1897-1901
  • 85 Bavaria J E, Kotloff R, Palevsky H et al.. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease.  J Thorac Cardiovasc Surg. 1997;  113 520-527 , discussion 528
  • 86 Patterson G A, Maurer J R, Williams T J et al.. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group.  J Thorac Cardiovasc Surg. 1991;  101 623-631 , discussion 631-622
  • 87 Sanchez Riera H, Montemayor Rubio T, Ortega Ruiz F et al.. Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise performance, and quality of life.  Chest. 2001;  120 748-756
  • 88 Bestall J C, Paul E A, Garrod R et al.. Longitudinal trends in exercise capacity and health status after pulmonary rehabilitation in patients with COPD.  Respir Med. 2003;  97 173-180
  • 89 Revill S M, Singh S J, Morgan M D. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD.  Respir Med. 2000;  94 778-783
  • 90 Geddes D, Davies M, Koyama H et al.. Effect of lung-volume-reduction surgery in patients with severe emphysema.  N Engl J Med. 2000;  343 239-245
  • 91 Morgan C J, Singh S J, Shah D, Morgan M DL. The sensitivity of the incremental & endurance shuttle walking tests to ambulatory oxygen [abstract].  Am J Respir Crit Care Med. 2003;  167 A670
  • 92 Mador M J, Kufel T J, Pineda L A et al.. Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.  Am J Respir Crit Care Med. 2001;  163 930-935
  • 93 Palange P, Forte S, Onorati P et al.. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD.  J Appl Physiol. 2000;  88 1715-1720
  • 94 O'Donnell D E, Lam M, Webb K A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  160 542-549
  • 95 O'Donnell D E, Lam M, Webb K A. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1998;  158 1557-1565
  • 96 Belman M J, Botnick W C, Shin J W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1996;  153 967-975
  • 97 Szekely L A, Oelberg D A, Wright C et al.. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery.  Chest. 1997;  111 550-558
  • 98 Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation.  J Heart Lung Transplant. 1997;  16 313-319
  • 99 Bittner V, Weiner D H, Yusuf S et al.. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators.  JAMA. 1993;  270 1702-1707
  • 100 Enright P L, Sherrill D L. Reference equations for the six-minute walk in healthy adults.  Am J Respir Crit Care Med. 1998;  158 1384-1387
  • 101 Ikegami Y, Hiruta S, Ikegami H, Miyamura M. Development of a telemetry system for measuring oxygen uptake during sports activities.  Eur J Appl Physiol Occup Physiol. 1988;  57 622-626
  • 102 Crandall C G, Taylor S L, Raven P B. Evaluation of the Cosmed K2 portable telemetric oxygen uptake analyzer.  Med Sci Sports Exerc. 1994;  26 108-111
  • 103 Kawakami Y, Nozaki D, Matsuo A, Fukunaga T. Reliability of measurement of oxygen uptake by a portable telemetric system.  Eur J Appl Physiol Occup Physiol. 1992;  65 409-414
  • 104 Novitsky S, Segal K R, Chatr-Aryamontri B et al.. Validity of a new portable indirect calorimeter: the AeroSport TEEM 100.  Eur J Appl Physiol Occup Physiol. 1995;  70 462-467
  • 105 Schulz H, Helle S, Heck H. The validity of the telemetric system CORTEX X1 in the ventilatory and gas exchange measurement during exercise.  Int J Sports Med. 1997;  18 454-457
  • 106 Melanson E L, Freedson P S, Hendelman D, Debold E. Reliability and validity of a portable metabolic measurement system.  Can J Appl Physiol. 1996;  21 109-119
  • 107 Casaburi R, Barstow T J, Robinson T, Wasserman K. Influence of work rate on ventilatory and gas exchange kinetics.  J Appl Physiol. 1989;  67 547-555
  • 108 Chuang M L, Ting H, Otsuka T et al.. Muscle deoxygenation as related to work rate.  Med Sci Sports Exerc. 2002;  34 1614-1623
  • 109 Le Masurier G C, Tudor-Locke C. Comparison of pedometer and accelerometer accuracy under controlled conditions.  Med Sci Sports Exerc. 2003;  35 867-871
  • 110 Bouten C V, Westerterp K R, Verduin M, Janssen J D. Assessment of energy expenditure for physical activity using a triaxial accelerometer.  Med Sci Sports Exerc. 1994;  26 1516-1523
  • 111 Steele B G, Holt L, Belza B et al.. Quantitating physical activity in COPD using a triaxial accelerometer.  Chest. 2000;  117 1359-1367
  • 112 Bouten C V, Verboeket-van de Venne W P, Westerterp K R et al.. Daily physical activity assessment: comparison between movement registration and doubly labeled water.  J Appl Physiol. 1996;  81 1019-1026
  • 113 Belza B, Steele B G, Hunziker J et al.. Correlates of physical activity in chronic obstructive pulmonary disease.  Nurs Res. 2001;  50 195-202
  • 114 Starling R D, Matthews D E, Ades P A, Poehlman E T. Assessment of physical activity in older individuals: a doubly labeled water study.  J Appl Physiol. 1999;  86 2090-2096
  • 115 Chen K Y, Sun M. Improving energy expenditure estimation by using a triaxial accelerometer.  J Appl Physiol. 1997;  83 2112-2122
  • 116 Steele B G, Belza B, Hunziker J et al.. Monitoring daily activity during pulmonary rehabilitation using a triaxial accelerometer.  J Cardiopulm Rehabil. 2003;  23 139-142
  • 117 Schonhofer B, Ardes P, Geibel M et al.. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease.  Eur Respir J. 1997;  10 2814-2819
  • 118 Jakicic J M, Marcus M, Gallagher K I et al.. Evaluation of the SenseWear Pro Armband to assess energy expenditure during exercise.  Med Sci Sports Exerc. 2004;  36 897-904
  • 119 Fruin M L, Rankin J W. Validity of a multi-sensor armband in estimating rest and exercise energy expenditure.  Med Sci Sports Exerc. 2004;  36 1063-1069
  • 120 King G A, Torres N, Potter C et al.. Comparision of activity monitors to estimate energy cost of treadmill exercise.  Med Sci Sports Exerc. 2004;  36 1244-1251
  • 121 Patel S A, Slivka W A, Sciurba F C. Validation of a wearable body monitoring device in COPD.  Am J Respir Crit Care Med. 2004;  169 A771
  • 122 Matthews C E, Ainsworth B E, Thompson R W, Bassett Jr D R. Sources of variance in daily physical activity levels as measured by an accelerometer.  Med Sci Sports Exerc. 2002;  34 1376-1381

Frank C SciurbaM.D. 

Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh

3471 Fifth Ave., Ste. 1211 Kaufmann Bldg.

Pittsburgh, PA 15213

Email: sciurbafc@upmc.edu

    >